InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-66.6%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Liu David Y, Directeur Scientifique. Insider active across 1 company, notably Protagonist Therapeutics, Inc. In total, 6 filings have been logged. History available since 17 August 2021. The latest transaction was filed on 16 November 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
13,767 shares@ US$0.8716.0% of flowCommon StockSEC:0001104659-22-119974:0
2,119 shares@ US$24.280.0008% mcap75.6% of flowCommon StockSEC:0001104659-22-029519:0
10,000 shares0Common StockSEC:0001104659-22-024840:0
10,000 shares0Common StockSEC:0001104659-22-024840
10,000 shares@ US$0.870.0001% mcap12.2% of flowCommon StockSEC:0001104659-21-107818:0
10,000 shares@ US$0.8710.3% of flowCommon StockSEC:0001104659-21-107818
6 of 6 declarations
About Liu David Y
Liu David Y serves as the Chief Scientific Officer at Protagonist Therapeutics, Inc. He is responsible for leading scientific research and product development. His role is crucial for innovation and advancing the company's research goals.
